tiprankstipranks
Acumen Pharmaceuticals Revises ALTITUDE-AD Study Phase
PremiumCompany AnnouncementsAcumen Pharmaceuticals Revises ALTITUDE-AD Study Phase
1M ago
Acumen Pharmaceuticals to Participate in the Stifel 2024 CNS Days
PremiumPress Releases
Acumen Pharmaceuticals to Participate in the Stifel 2024 CNS Days
1M ago
Acumen Pharmaceuticals Presents Sabirnetug (ACU193) Fluid Biomarker and Target Engagement Analyses from Phase 1 INTERCEPT-AD Study in Early Alzheimer’s at the AD/PD™ 2024 Annual Meeting
PremiumPress Releases
Acumen Pharmaceuticals Presents Sabirnetug (ACU193) Fluid Biomarker and Target Engagement Analyses from Phase 1 INTERCEPT-AD Study in Early Alzheimer’s at the AD/PD™ 2024 Annual Meeting
1M ago
Acumen appoints Doherty as President, Chief Development Officer
PremiumThe FlyAcumen appoints Doherty as President, Chief Development Officer
3M ago
Acumen Pharmaceuticals Appoints Dr. James Doherty as President and Chief Development Officer
PremiumPress Releases
Acumen Pharmaceuticals Appoints Dr. James Doherty as President and Chief Development Officer
3M ago
Acumen Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
PremiumPress Releases
Acumen Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100